Human medicines
Trobalt
The marketing authorization holder has informed its supplied customers in a letter dated 23.06.2017 that due to the global decision of the company,…
Elotrace
The marketing authorization holder has informed its supplied customers in a letter dated May 23, 2017, that increased black visible particles have…
Albiomin
The marketing authorization holder has informed its supplied customers in a letter dated April 27, 2017, that the affected batches are being recalled…
Extended recall of EpiPen 300 micrograms and EpiPen Junior 150 micrograms solution for injection in a prefilled pen (epinephrine)
EpiPen recall 2
The marketing authorization holder has informed its supplied customers about the extended voluntary recall of additional EpiPen batches in a letter…
Buerlecithin
The marketing authorization holder has informed its supplied customers in a letter dated April 6, 2017, that individual bottles filled with 100 ml of…
Recall of "EpiPen 300 micrograms solution for injection in a ready-to-use pen".
EpiPen recall 1
The marketing authorization holder informed its supplied customers in a letter dated March 23, 2017, that there is a very low probability that the…
Adalat
The marketing authorization holder has informed its supplied customers in a letter dated 22.2.2017 that a possible contamination with another active…
Kyprolis
The marketing authorization holder informed its supplied customers in a letter dated December 15, 2016, that the vials may have cracks in the glass.…
